Neurology

Pharmacovigilance Market to Reach $26.2 billion, Globally, by 2034 at 12.3% CAGR: Allied Market Research

Pharmacovigilance is increasingly adopted across pharmaceutical companies, regulatory bodies, clinical research organizations, and healthcare providers due to its critical role…

4 weeks ago

PhaseV Earns Three Prestigious Industry Awards Highlighting Leadership in AI for Clinical Development

Company Included in CB Insights' Digital Health 50 List, TechCrunch's AI Disruptors 60 List and Named BioTech Breakthrough 'Analytics Solution…

4 weeks ago

Using Skin Biopsy Technology, CND Life Sciences Performs the 50,000th Syn-One Test® for Patients

Launched in 2019, the Syn-One Test is used by neurologists and other clinicians in all 50 states to aid in…

4 weeks ago

NewcelX Announces Scientific Leadership with the Head of Division of Medical Neurosciences at the Department of Neurology at Hadassah, Prof. Tamir Ben-Hur on Its Scientific Advisory Board

ZURICH, Nov. 6, 2025 /PRNewswire/ -- NewcelX Ltd. (NASDAQ: NCEL) ("NewcelX" or the "Company"), a biotechnology company advancing transformative therapies for…

4 weeks ago

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results

Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use…

4 weeks ago

Tekton Research Selects Todata’s SiteGrades and Tod AI as Enterprise Business Intelligence Solution

OMAHA, Neb., Nov. 5, 2025 /PRNewswire/ -- Tekton Research, a leading multispecialty clinical trial site organization conducting Phase 1-4 trials,…

1 month ago

Bausch Health’s OraPharma Expands into Canada and Puerto Rico, Helping to Address Unmet Needs in Periodontal Disease

Expansion improves access to treatment options within periodontal care and helps strengthen partnerships with dental professionals within these populations. LAVAL,…

1 month ago

Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities

Group revenues of € 535.1 m ((7.1)%); Discovery & Preclinical Development segment ("D&PD", (12.3)%) still sees soft demand;Just - Evotec…

1 month ago

Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December

PHILADELPHIA, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and…

1 month ago

CEFALY Marks a Milestone: #1 Neuromodulation Device Prescribed by Veterans Health Administration Providers

DARIEN, Conn., Nov. 3, 2025 /PRNewswire/ -- Medical device maker CEFALY Technology announced today that CEFALY Connected has become the…

1 month ago